Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member
tabling member	label

Search

1504776

registered interest
date	05/09/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Temporary Employment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the total cost to NHS hospitals was of using (a) agency and (b) bank staff in each region in England in the 2021-22 financial year.
tabling member constituency	Enfield North
tabling member printed	Feryal Clark
uin	47698
answer	answer is ministerial correction date of answer 20/09/2022 answer text <p>The information requested is not yet held in the format requested as the accounts for 2021/22 are currently being audited.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 20/09/2022 14:35:04 answering member 4320 label Biography information for Robert Jenrick previous answer version 17726 answering member constituency Suffolk Coastal answering member printed Dr Thérèse Coffey answering member 4098
tabling member	4822 label Biography information for Feryal Clark

1505139

registered interest
date	05/09/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Nurses: Recruitment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he expects eligible post-graduate nurses to receive the £10,000 golden hello payment announced in May 2018.
tabling member constituency	Kingston upon Hull East
tabling member printed	Karl Turner
uin	47512
answer	answer is ministerial correction date of answer 20/09/2022 answer text <p>In May 2018, we announced the intention to pay a ‘golden hello’ to nurses who started a postgraduate course in learning disability nursing, mental health nursing or district nursing in the 2018/19 academic year who subsequently qualified and were employed in these roles in the health and care sector.</p><p>The Government is considering the most effective way to administer and introduce any scheme to ensure it delivers on the original intent.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 20/09/2022 14:37:11 answering member 4320 label Biography information for Robert Jenrick previous answer version 17720 answering member constituency Suffolk Coastal answering member printed Dr Thérèse Coffey answering member 4098
tabling member	4030 label Biography information for Karl Turner

1505163

registered interest
date	05/09/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Tixagevimab/cilgavimab
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he expects NICE's review of Evusheld to be concluded.
tabling member constituency	North Durham
tabling member printed	Mr Kevan Jones
uin	47379
answer	answer is ministerial correction date of answer 20/09/2022 answer text <p>On 10 August 2022, the Department referred tixagevimab and cilgavimab (Evusheld) to the National Institute for Health and Care Excellence (NICE) to evaluate its clinical and cost effectiveness for preventing COVID-19. Between 29 July and 12 August, NICE consulted with stakeholders on the suggested remit, draft scope and list of consultees and commentators.</p><p>NICE has commenced this evaluation and currently expects to publish draft guidance in April 2023, with final guidance to follow in May 2023. In discussion with AstraZeneca, NICE is expediting the appraisal process by bringing forward the deadline for the manufacturer’s evidence submission.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 20/09/2022 14:34:16 answering member 4320 label Biography information for Robert Jenrick previous answer version 17716 answering member constituency Suffolk Coastal answering member printed Dr Thérèse Coffey answering member 4098
tabling member	1438 label Biography information for Mr Kevan Jones

1503771

registered interest
date	02/09/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hull University Teaching Hospitals NHS Trust: Accident and Emergency Departments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to help reduce Accident & Emergency waiting times at Hull University Teaching Hospitals NHS Trust.
tabling member constituency	Kingston upon Hull North
tabling member printed	Dame Diana Johnson
uin	45356
answer	answer is ministerial correction date of answer 22/09/2022 answer text <p>In order to mitigate the impact of the number of admitted patients who no longer have medical Criteria to Reside and cannot be swiftly discharged on accident and emergency services, Humber and North Integrated Care Board held a winter planning summit in August to identify actions and risks on patient flow and system pressures.</p><p>Hull University Teaching Hospitals NHS Trust is examining measures to improve average length of stay within acute wards to improve flow from the emergency department; identify actions with ambulance service and system partners to improve ambulance handover times; change clinical pathways to turn around more patients on the same day; and improve morning discharges. The Trust has also opened approximately 100 additional beds to support the management of No Criteria to Reside patients.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 22/09/2022 14:08:52 answering member 4320 label Biography information for Robert Jenrick
tabling member	1533 label Biography information for Dame Diana Johnson

1503839

registered interest
date	02/09/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Emergency Calls and NHS 111
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of levels of public knowledge of (a) the roles and purposes of 999 and NHS 111 and (b) when it is appropriate to contact each service respectively.
tabling member constituency	Twickenham
tabling member printed	Munira Wilson
uin	45587
answer	answer is ministerial correction date of answer 22/09/2022 answer text <p>No formal assessment has been made.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 22/09/2022 14:09:50 answering member 4320 label Biography information for Robert Jenrick
tabling member	4776 label Biography information for Munira Wilson

1503849

registered interest
date	02/09/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Clinical Trials: Standards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Life Science competitiveness indicators 2022, published in July 2022, what assessment he has made of the performance of the UK in the metric for median time from clinical trial application and the first patient receiving a first dose for a subset of commercial trials.
tabling member constituency	Leeds North West
tabling member printed	Alex Sobel
uin	45598
answer	answer is ministerial correction date of answer 22/09/2022 answer text <p>The annual Life Sciences competitiveness indicators have highlighted that trial establishment times in the United Kingdom are slower than several of our competitors. In 2022, indicators showed that the median time was 247 days for a subset of commercial trials, with the UK ranked seventh out of 10. In March 2021, we published ‘Saving and Improving Lives: The Future of UK Clinical Research Delivery’ which highlighted improving the speed and efficiency of study set-up. This is being taken forward through the Recovery Resilience and Growth Programme. The Programme’s delivery partners are simplifying and streamlining processes to improve the median time from clinical application and first patient.</p><p>In 2021, a combined review by the Health Research Authority (HRA) and the Medicines and Healthcare products Regulatory Agency (MHRA) reduced approval times for clinical trials to 61 days, compared to 90 days for those that did not go through combined review. ‘The Future of UK Clinical Research Delivery: 2022 to 2025 implementation plan’, published on 30 June 2022, includes actions designed to improve set-up times over the remainder of this Parliament, including:</p><p>- Implementing the UK-wide National Contract Value Review for commercial research to ensure costing does not delay study set-up in the National Health Service;</p><p>- Introduction of a single UK approval service to replace the HRA and Health Care Research Wales’ approval and equivalent processes in Northern Ireland and Scotland; and</p><p>- Further development of the Integrated Research Application System by the HRA and the MHRA to streamline health technology and medicines research.</p> answering member constituency Newark answering member printed Robert Jenrick grouped question UIN 45435 question first answered 22/09/2022 14:16:09 answering member 4320 label Biography information for Robert Jenrick
tabling member	4658 label Biography information for Alex Sobel

1503850

registered interest
date	02/09/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Clinical Trials: Standards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Life science competitiveness indicators published in July 2022, what steps his Department is taking to reduce the median time from clinical trial application to the first patient receiving a first dose for a subset of commercial trials.
tabling member constituency	Leeds North West
tabling member printed	Alex Sobel
uin	45435
answer	answer is ministerial correction date of answer 22/09/2022 answer text <p>The annual Life Sciences competitiveness indicators have highlighted that trial establishment times in the United Kingdom are slower than several of our competitors. In 2022, indicators showed that the median time was 247 days for a subset of commercial trials, with the UK ranked seventh out of 10. In March 2021, we published ‘Saving and Improving Lives: The Future of UK Clinical Research Delivery’ which highlighted improving the speed and efficiency of study set-up. This is being taken forward through the Recovery Resilience and Growth Programme. The Programme’s delivery partners are simplifying and streamlining processes to improve the median time from clinical application and first patient.</p><p>In 2021, a combined review by the Health Research Authority (HRA) and the Medicines and Healthcare products Regulatory Agency (MHRA) reduced approval times for clinical trials to 61 days, compared to 90 days for those that did not go through combined review. ‘The Future of UK Clinical Research Delivery: 2022 to 2025 implementation plan’, published on 30 June 2022, includes actions designed to improve set-up times over the remainder of this Parliament, including:</p><p>- Implementing the UK-wide National Contract Value Review for commercial research to ensure costing does not delay study set-up in the National Health Service;</p><p>- Introduction of a single UK approval service to replace the HRA and Health Care Research Wales’ approval and equivalent processes in Northern Ireland and Scotland; and</p><p>- Further development of the Integrated Research Application System by the HRA and the MHRA to streamline health technology and medicines research.</p> answering member constituency Newark answering member printed Robert Jenrick grouped question UIN 45598 question first answered 22/09/2022 14:16:09 answering member 4320 label Biography information for Robert Jenrick
tabling member	4658 label Biography information for Alex Sobel

1503896

registered interest
date	02/09/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	World Health Organization
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department will be represented at the World Health Organisation Regional Committee Meeting for Europe between 12-14 September 2022.
tabling member constituency	Clwyd West
tabling member printed	Mr David Jones
uin	45556
answer	answer is ministerial correction date of answer 20/09/2022 answer text <p>The United Kingdom’s delegation will be led by the Department of Health and Social Care, with officials from the Foreign, Commonwealth and Development Office, the UK Health Security Agency, NHS England and the Welsh Government.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 20/09/2022 14:26:11 answering member 4320 label Biography information for Robert Jenrick previous answer version 17527 answering member constituency Erewash answering member printed Maggie Throup answering member 4447
tabling member	1502 label Biography information for Mr David Jones

1503914

registered interest
date	02/09/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Infectious Diseases: Disease Control
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent discussions he has had with representatives of the World Health Organisation on progress towards a new convention, agreement, or other international instrument on pandemic prevention, preparedness and response; whether the target for agreeing this remains May 2024; and if he will make a statement.
tabling member constituency	Cynon Valley
tabling member printed	Beth Winter
uin	45531
answer	answer is ministerial correction date of answer 22/09/2022 answer text <p>The United Kingdom is working with international partners on an instrument on pandemic preparedness and responses, including at the most recent meeting of the Intergovernmental Negotiating Body (INB). This is the Member State-led process for drafting and negotiating the pandemic instrument, held during the week commencing 18 July 2022. Officials from the Department of Health and Social Care and the Foreign, Commonwealth and Development Office participated in discussions with Member States and representatives of the World Health Organization (WHO).</p><p>The next meeting of the INB is scheduled for the 5 to 7 December 2022, with the aim of agreeing this instrument in May 2024 at the World Health Assembly. The UK will use inter-sessional time between meetings to engage further with Member States and WHO officials, including at forthcoming WHO regional committees.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 22/09/2022 14:11:30 answering member 4320 label Biography information for Robert Jenrick
tabling member	4809 label Biography information for Beth Winter

1504262

registered interest
date	02/09/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Junior Doctors: Pay
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of awarding NHS junior doctors a higher pay rise than set out in the agreed 2019 four-year pay settlement in the context of the rising cost of living.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	45809
answer	answer is ministerial correction date of answer 22/09/2022 answer text <p>Junior doctors have a pre-existing multi-year pay and contract reform deal agreed with the trade union. As well as setting annual pay increases, the deal made improvements to terms and conditions and further strengthened safety and rest limits. Alongside investment in pay, the Government has also invested £90 million to create a new higher pay point for the most experienced junior doctors, increase allowances for those working the most frequently at weekends, enhance eligibility for night shift pay and create a £1,000 a year allowance for junior doctors working less than full time to help with the cost of training. The multi-year deal ends in 2023 and the Government will consider next year’s pay increase with evidence on recruitment and retention.</p> answering member constituency Newark answering member printed Robert Jenrick grouped question UIN 45810 question first answered 22/09/2022 14:18:31 answering member 4320 label Biography information for Robert Jenrick
tabling member	4079 label Biography information for Julian Sturdy